Novalis Biotech — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Alithea Genomicsalitheagenomics.comin𝕏Mar 2026 · $8.9M
Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development.
AgTechBiotechDeep TechHealthtechLausanne, CH
Riccardo Dainese(CCO and Co-founder)inDaniel Alpern(CSO and Co-founder)in
Co-investorsKickfund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.